![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EMD |
Gene summary for EMD |
![]() |
Gene information | Species | Human | Gene symbol | EMD | Gene ID | 2010 |
Gene name | emerin | |
Gene Alias | EDMD | |
Cytomap | Xq28 | |
Gene Type | protein-coding | GO ID | GO:0003008 | UniProtAcc | P50402 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2010 | EMD | HTA11_3410_2000001011 | Human | Colorectum | AD | 5.33e-04 | 1.55e-01 | 0.0155 |
2010 | EMD | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.89e-07 | 2.87e-01 | -0.1808 |
2010 | EMD | HTA11_2951_2000001011 | Human | Colorectum | AD | 3.87e-02 | 2.79e-01 | 0.0216 |
2010 | EMD | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.62e-02 | 1.92e-01 | -0.0811 |
2010 | EMD | HTA11_347_2000001011 | Human | Colorectum | AD | 9.56e-08 | 2.62e-01 | -0.1954 |
2010 | EMD | HTA11_411_2000001011 | Human | Colorectum | SER | 4.39e-03 | 5.71e-01 | -0.2602 |
2010 | EMD | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.66e-07 | 3.99e-01 | -0.1207 |
2010 | EMD | HTA11_696_2000001011 | Human | Colorectum | AD | 9.34e-11 | 3.22e-01 | -0.1464 |
2010 | EMD | HTA11_866_2000001011 | Human | Colorectum | AD | 9.11e-06 | 1.76e-01 | -0.1001 |
2010 | EMD | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.20e-12 | 4.34e-01 | -0.059 |
2010 | EMD | HTA11_546_2000001011 | Human | Colorectum | AD | 4.12e-04 | 3.86e-01 | -0.0842 |
2010 | EMD | HTA11_866_3004761011 | Human | Colorectum | AD | 7.05e-07 | 3.06e-01 | 0.096 |
2010 | EMD | HTA11_8622_2000001021 | Human | Colorectum | SER | 4.20e-02 | 2.58e-01 | 0.0528 |
2010 | EMD | HTA11_7663_2000001011 | Human | Colorectum | SER | 4.64e-03 | 3.78e-01 | 0.0131 |
2010 | EMD | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.32e-03 | 2.20e-01 | 0.0338 |
2010 | EMD | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.69e-14 | 3.25e-01 | 0.0674 |
2010 | EMD | HTA11_7469_2000001011 | Human | Colorectum | AD | 9.89e-03 | 4.64e-01 | -0.0124 |
2010 | EMD | HTA11_6818_2000001021 | Human | Colorectum | AD | 2.39e-05 | 3.90e-01 | 0.0588 |
2010 | EMD | HTA11_99999970781_79442 | Human | Colorectum | MSS | 3.63e-12 | 3.19e-01 | 0.294 |
2010 | EMD | HTA11_99999965104_69814 | Human | Colorectum | MSS | 6.42e-14 | 4.55e-01 | 0.281 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005116912 | Liver | Cirrhotic | nuclear transport | 118/4634 | 301/18723 | 1.71e-08 | 6.27e-07 | 118 |
GO:004682211 | Liver | Cirrhotic | regulation of nucleocytoplasmic transport | 51/4634 | 106/18723 | 1.54e-07 | 4.12e-06 | 51 |
GO:005116812 | Liver | Cirrhotic | nuclear export | 67/4634 | 154/18723 | 2.57e-07 | 6.41e-06 | 67 |
GO:001605511 | Liver | Cirrhotic | Wnt signaling pathway | 150/4634 | 444/18723 | 9.75e-06 | 1.42e-04 | 150 |
GO:019873811 | Liver | Cirrhotic | cell-cell signaling by wnt | 150/4634 | 446/18723 | 1.28e-05 | 1.80e-04 | 150 |
GO:003011111 | Liver | Cirrhotic | regulation of Wnt signaling pathway | 112/4634 | 328/18723 | 7.57e-05 | 8.40e-04 | 112 |
GO:00468246 | Liver | Cirrhotic | positive regulation of nucleocytoplasmic transport | 29/4634 | 62/18723 | 1.34e-04 | 1.31e-03 | 29 |
GO:00066114 | Liver | Cirrhotic | protein export from nucleus | 27/4634 | 57/18723 | 1.74e-04 | 1.63e-03 | 27 |
GO:00468256 | Liver | Cirrhotic | regulation of protein export from nucleus | 17/4634 | 30/18723 | 1.87e-04 | 1.74e-03 | 17 |
GO:006082811 | Liver | Cirrhotic | regulation of canonical Wnt signaling pathway | 86/4634 | 253/18723 | 5.70e-04 | 4.46e-03 | 86 |
GO:0048145 | Liver | Cirrhotic | regulation of fibroblast proliferation | 33/4634 | 80/18723 | 8.46e-04 | 6.12e-03 | 33 |
GO:0048144 | Liver | Cirrhotic | fibroblast proliferation | 33/4634 | 81/18723 | 1.09e-03 | 7.59e-03 | 33 |
GO:0006997 | Liver | Cirrhotic | nucleus organization | 48/4634 | 133/18723 | 2.27e-03 | 1.38e-02 | 48 |
GO:006007011 | Liver | Cirrhotic | canonical Wnt signaling pathway | 97/4634 | 303/18723 | 2.42e-03 | 1.46e-02 | 97 |
GO:0071763 | Liver | Cirrhotic | nuclear membrane organization | 15/4634 | 33/18723 | 7.61e-03 | 3.60e-02 | 15 |
GO:003238621 | Liver | HCC | regulation of intracellular transport | 231/7958 | 337/18723 | 1.99e-22 | 3.40e-20 | 231 |
GO:000691322 | Liver | HCC | nucleocytoplasmic transport | 208/7958 | 301/18723 | 5.51e-21 | 8.12e-19 | 208 |
GO:005116922 | Liver | HCC | nuclear transport | 208/7958 | 301/18723 | 5.51e-21 | 8.12e-19 | 208 |
GO:003315721 | Liver | HCC | regulation of intracellular protein transport | 165/7958 | 229/18723 | 8.37e-20 | 1.15e-17 | 165 |
GO:003238821 | Liver | HCC | positive regulation of intracellular transport | 148/7958 | 202/18723 | 5.15e-19 | 6.66e-17 | 148 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EMD | SNV | Missense_Mutation | c.700G>T | p.Val234Phe | p.V234F | P50402 | protein_coding | deleterious(0.02) | benign(0.235) | TCGA-AN-A0AM-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
EMD | SNV | Missense_Mutation | c.173N>G | p.Ser58Cys | p.S58C | P50402 | protein_coding | tolerated(0.07) | possibly_damaging(0.75) | TCGA-C5-A1M6-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD | |
EMD | SNV | Missense_Mutation | c.720N>A | p.Phe240Leu | p.F240L | P50402 | protein_coding | tolerated(1) | benign(0) | TCGA-DS-A1OC-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | gemcitabine | SD | |
EMD | SNV | Missense_Mutation | rs782057378 | c.662N>A | p.Arg221His | p.R221H | P50402 | protein_coding | deleterious(0) | benign(0) | TCGA-AA-3662-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | capecitabine | PR |
EMD | SNV | Missense_Mutation | c.661C>T | p.Arg221Cys | p.R221C | P50402 | protein_coding | deleterious(0) | benign(0.441) | TCGA-AD-6889-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | xeloda | PD | |
EMD | SNV | Missense_Mutation | c.146N>T | p.Ser49Leu | p.S49L | P50402 | protein_coding | tolerated(0.12) | benign(0.005) | TCGA-AZ-4313-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
EMD | SNV | Missense_Mutation | novel | c.407A>C | p.Asp136Ala | p.D136A | P50402 | protein_coding | tolerated(0.05) | benign(0.003) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
EMD | SNV | Missense_Mutation | c.610C>A | p.Arg204Ser | p.R204S | P50402 | protein_coding | deleterious(0.01) | benign(0.182) | TCGA-CK-5913-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
EMD | SNV | Missense_Mutation | c.752G>T | p.Gly251Val | p.G251V | P50402 | protein_coding | deleterious(0.01) | benign(0.298) | TCGA-AF-A56N-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Chemotherapy | xeloda | CR | |
EMD | SNV | Missense_Mutation | rs782768362 | c.385N>A | p.Ala129Thr | p.A129T | P50402 | protein_coding | tolerated(1) | benign(0) | TCGA-EI-6508-01 | Colorectum | rectum adenocarcinoma | Female | <65 | III/IV | Chemotherapy | oxaliplatin | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |